Searched for
CDSCO SCRUTINY OF PHARMA DRUGS
CDSCO steps up scrutiny of pharma drugs containing narcotic substancesThe Central Drugs Standard Control Organisation is addressing regulatory gaps related to the illegal diversion of pharmaceutical drugs. Fol...- Rs 78,400 vs Rs 7,750 medicine: Novartis, Eli Lilly oppose bid to cut breast cancer drug prices in IndiaNovartis and Eli Lilly have opposed a Kerala High Court petition seeking government intervention to make two breast cancer drugs cheaper, d...
- Virtual pharma API firm HRV preparing for IPO, DRHP likely in H1 of 2027: SourcesHRV Pharma CEO Hari Kiran Chereddi says investing in capacity at partner facilities, exploring acquisitions for market access; forecasts Rs...
- GLP-1 users are suing over vision loss: What does the evidence really show?Dozens of patients have taken legal action against drug manufacturers, filing personal injury lawsuits that allege they were not adequately...
- NHRC proposes central drug registry, real-time tracking to curb spurious medicinesThe National Human Rights Commission has recommended implementing a centralised registration system for medicines in India. This system aim...
- Duty-free shops not exempt from Indian laws, Bombay HC upholds ban on nicotine pouchesThe Bombay High Court recently upheld a ban on imported nicotine pouches at Mumbai's airport. The court maintained that imported goods must...
- Court rejects Adani plea that duty-free shops are beyond domestic lawsAn Indian court has ruled that nicotine pouches sold at duty-free shops are subject to domestic laws. The Adani Group challenged the legali...
- 'Inflated medicine prices are daylight robbery': SC pulls up pharma companies over huge MRP-PTR gapSupreme Court on Tuesday questioned the wide gap between the price to retailer and MRP of some cancer medicines, calling inflated pricing a...
- Drug regulator warns against prolonged use of painkillers, antibioticsIndia’s drug regulator has warned against the indiscriminate, repeated or prolonged use of painkillers and antibiotics, citing risks includ...
- MF Tracker: HDFC Pharma & Healthcare Fund tops equity MFs at 25% in 1 year. Should investors chase the rally?HDFC Pharma and Healthcare Fund recorded an impressive 25% return in the last year, surpassing its category average across various time fra...
- Before giving cough syrup to your child, check the bottle: Sale still continues despite advisory for kids under 4; check what changes are being plannedIndia's drug regulatory authority is evaluating the introduction of new warning labels for cough syrups. These proposed labels will promine...
- Cough syrup bottles may soon carry a warning label in 'red'The move comes amid continued concerns over the prescribing of cough syrups to infants and young children, despite a directorate general of...
- Takeda partners Dr Reddy's to launch dengue vaccine Qdenga in India from 2027Takeda and Dr. Reddy's Labs will promote the Qdenga dengue vaccine in India. This pioneering vaccine is expected to launch in the first hal...
- Drugs Panel to weigh bringing all sterile drug products under central licensing amid contamination concernsA proposal will soon be considered to centralize licensing for all sterile drug products. This move aims to tighten regulations on medicine...
- ET Startup Awards 2026: Theranautilus’ nanorobots will be ready for human trials by year-endTheranautilus won the Top Innovator category at The Economic Times Startup Awards 2026 for its unique nanorobot technology, which is built ...
- Hospitals seek new pricing rules as Maharashtra FDA flags high markupsThe healthcare industry seeks a differentiated framework for medical device pricing reviews. Hospitals incur significant costs beyond procu...
- Supreme Court upholds Himachal HC ruling on drug regulator powers, impacting CDSCO enforcementThe Supreme Court dismissed the Union government's challenge to a High Court judgment. This ruling clarified jurisdiction over drug regulat...
- Agonisingly slow clinical trial is stopping Indian pharma become global innovator from supplierIndia's regulatory hurdles slow down early-stage drug trials significantly. This complexity causes Indian companies to conduct crucial firs...
- Fake Cancer Drug Racket Busted: A man was selling counterfeit medicines to 100 hospitals across Bengaluru and other statesA major fake cancer drug racket has been busted in Karnataka, with investigators alleging that a licensed pharmacist supplied counterfeit m...
- CBIC releases import clearance checklist for cosmetics, drugs, and medical devicesThe CBIC has introduced a new checklist for customs officers reviewing imports. This standardized process aims to streamline clearances for...
Load More
